Table of contents
Volume 90, Issue 2
Published online 20 January 2004 (283-560)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor |
Book Reviews
Minireviews
Conferring specificity on the ubiquitous Raf/MEK signalling pathway FREE
E O'Neill and W Kolch
Br J Cancer 90: 283-288; doi:10.1038/sj.bjc.6601488
Negative regulation of ErbB family receptor tyrosine kinases FREE
C Sweeney and K L Carraway III
Br J Cancer 90: 289-293; doi:10.1038/sj.bjc.6601500
Second primary breast cancer after Hodgkin's disease FREE
A Horwich and A J Swerdlow
Br J Cancer 90: 294-298; doi:10.1038/sj.bjc.6601499
Modifiable risk factors for cancer FREE
C J Stein and G A Colditz
Br J Cancer 90: 299-303; doi:10.1038/sj.bjc.6601509
Clinical
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens FREE
J S Kloover, M A den Bakker, H Gelderblom and J P van Meerbeeck
Br J Cancer 90: 304-305; doi:10.1038/sj.bjc.6601303
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer FREE
R Petrioli, M Sabatino, A I Fiaschi, S Marsili, D Pozzessere, S Messinese, P Correale, S Civitelli, G Tanzini, F Tani, A De Martino, G Marzocca, M Lorenzi, G Giorgi and G Francini
Br J Cancer 90: 306-309; doi:10.1038/sj.bjc.6601521
Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention FREE
M Sharpe, V Strong, K Allen, R Rush, P Maguire, A House, A Ramirez and A Cull
Br J Cancer 90: 310-313; doi:10.1038/sj.bjc.6601546
Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs FREE
M Sharpe, V Strong, K Allen, R Rush, K Postma, A Tulloh, P Maguire, A House, A Ramirez and A Cull
Br J Cancer 90: 314-320; doi:10.1038/sj.bjc.6601578
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes FREE
E A Lobb, P N Butow, A Barratt, B Meiser, C Gaff, M A Young, E Haan, G Suthers, M Gattas and K Tucker
Br J Cancer 90: 321-327; doi:10.1038/sj.bjc.6601502
Patient–physician communication concerning participation in cancer chemotherapy trials FREE
J B Sørensen, P Rossel and S Holm
Br J Cancer 90: 328-332; doi:10.1038/sj.bjc.6601524
Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation FREE
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog and W A J van Daal
Br J Cancer 90: 333-342; doi:10.1038/sj.bjc.6601525
Factors affecting pharmacokinetic variability of oral topotecan: a population analysis FREE
F Léger, W J Loos, J Fourcade, R Bugat, M Goffinet, R H J Mathijssen, J Verweij, A Sparreboom and E Chatelut
Br J Cancer 90: 343-347; doi:10.1038/sj.bjc.6601469
Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) FREE
H Katori, M Tsukuda, I Mochimatu, J Ishitoya, S Kawai, Y Mikami, H Matsuda, Y Tanigaki, C Horiuchi, Y Ikeda, T Taguchi, M Ono, T Yoshida, S Hirose, Y Sakuma and K Yamamoto
Br J Cancer 90: 348-352; doi:10.1038/sj.bjc.6601471
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas FREE
A J M Ferreri, E Guerra, M Regazzi, F Pasini, A Ambrosetti, A Pivnik, A Gubkin, A Calderoni, M Spina, A Brandes, F Ferrarese, A Rognone, S Govi, S Dell'Oro, M Locatelli, E Villa and M Reni
Br J Cancer 90: 353-358; doi:10.1038/sj.bjc.6601472
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated FREE
Y-M Chen, R-P Perng, J-F Shih, Y-C Lee, C-S Lee, C-M Tsai and J Whang-Peng
Br J Cancer 90: 359-365; doi:10.1038/sj.bjc.6601526
A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion FREE
S H Ahmedzai, E Laude, A Robertson, G Troy and V Vora
Br J Cancer 90: 366-371; doi:10.1038/sj.bjc.6601527
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B FREE
G Todeschini, S Secchi, E Morra, U Vitolo, E Orlandi, F Pasini, E Gallo, A Ambrosetti, C Tecchio, C Tarella, A Gabbas, A Gallamini, L Gargantini, M Pizzuti, G Fioritoni, L Gottin, G Rossi, M Lazzarino, F Menestrina, M Paulli, M Palestro, M G Cabras, F Di Vito and G Pizzolo
Br J Cancer 90: 372-376; doi:10.1038/sj.bjc.6601460
Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma? FREE
B Gronlund, H H Hansen, C Høgdall, E V S Høgdall and S A Engelholm
Br J Cancer 90: 377-382; doi:10.1038/sj.bjc.6601501
Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy FREE
J H Groenewoud, R M Pijnappel, M E van den Akker-van Marle, E Birnie, T Buijs-van der Woude, W P Th M Mali, H J de Koning and E Buskens
Br J Cancer 90: 383-392; doi:10.1038/sj.bjc.6601520
Breast density as a determinant of interval cancer at mammographic screening FREE
S Ciatto, C Visioli, E Paci and M Zappa
Br J Cancer 90: 393-396; doi:10.1038/sj.bjc.6601548
Economics of the clinical management of lung cancer in France: an analysis using a Markov model FREE
C Chouaïd, L Molinier, C Combescure, J P Daurès, B Housset and A Vergnenègre
Br J Cancer 90: 397-402; doi:10.1038/sj.bjc.6601547
Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study FREE
H Mahteme, J Hansson, Å Berglund, L Påhlman, B Glimelius, P Nygren and W Graf
Br J Cancer 90: 403-407; doi:10.1038/sj.bjc.6601586
Potential health risks of complementary alternative medicines in cancer patients FREE
U Werneke, J Earl, C Seydel, O Horn, P Crichton and D Fannon
Br J Cancer 90: 408-413; doi:10.1038/sj.bjc.6601560
Molecular and Cellular Pathology
Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma FREE
Y Ito, E Miyoshi, N Sasaki, K Kakudo, H Yoshida, C Tomoda, T Uruno, Y Takamura, A Miya, K Kobayashi, F Matsuzuka, N Matsuura, K Kuma and A Miyauchi
Br J Cancer 90: 414-418; doi:10.1038/sj.bjc.6601540
The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype FREE
B Iacopetta, F Grieu and D Joseph
Br J Cancer 90: 419-422; doi:10.1038/sj.bjc.6601545
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ FREE
G P Boland, I S Butt, R Prasad, W F Knox and N J Bundred
Br J Cancer 90: 423-429; doi:10.1038/sj.bjc.6601534
Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours FREE
B M Fenton, S F Paoni, W Liu, S-Y Cheng, B Hu and I Ding
Br J Cancer 90: 430-435; doi:10.1038/sj.bjc.6601539
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence FREE
C Gu, T Oyama, T Osaki, J Li, M Takenoyama, H Izumi, K Sugio, K Kohno and K Yasumoto
Br J Cancer 90: 436-442; doi:10.1038/sj.bjc.6601531
Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients FREE
N Ady, L Morat, K Fizazi, J-C Soria, M-C Mathieu, D Prapotnich, L Sabatier and L Chauveinc
Br J Cancer 90: 443-448; doi:10.1038/sj.bjc.6601532
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence FREE
E Hernes, S D Fosså, Aa Berner, B Otnes and J M Nesland
Br J Cancer 90: 449-454; doi:10.1038/sj.bjc.6601536
Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells FREE
M D Hofer, A Menke, F Genze, P Gierschik and K Giehl
Br J Cancer 90: 455-462; doi:10.1038/sj.bjc.6601535
Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase FREE
J F Porter, S Shen and D T Denhardt
Br J Cancer 90: 463-470; doi:10.1038/sj.bjc.6601533
Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck FREE
P Mhawech, P Dulguerov, E Tschanz, C Verdan, C Ares and A S Allal
Br J Cancer 90: 471-475; doi:10.1038/sj.bjc.6601542
Genetics and Genomics
Variation in RNA expression and genomic DNA content acquired during cell culture FREE
L R Hiorns, T D Bradshaw, L A Skelton, Q Yu, L R Kelland and B Leyland-Jones
Br J Cancer 90: 476-482; doi:10.1038/sj.bjc.6601405
Germline truncating mutations in both MSH2 and BRCA2 in a single kindred FREE
I Thiffault, N Hamel, T Pal, S McVety, V A Marcus, D Farber, S Cowie, J Deschênes, W Meschino, F Odefrey, D Goldgar, T Graham, S Narod, A K Watters, E MacNamara, D Du Sart, G Chong and W D Foulkes
Br J Cancer 90: 483-491; doi:10.1038/sj.bjc.6601424
Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas FREE
R F Rodrigues, L Roque, J Rosa-Santos, O Cid and J Soares
Br J Cancer 90: 492-496; doi:10.1038/sj.bjc.6601530
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk FREE
A Baccarelli, D Calista, P Minghetti, B Marinelli, B Albetti, T Tseng, M Hedayati, L Grossman, G Landi, J P Struewing and M T Landi
Br J Cancer 90: 497-502; doi:10.1038/sj.bjc.6601385
Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma FREE
N Soufir, J J Lacapere, G Bertrand, E Matichard, R Meziani, D Mirebeau, V Descamps, B Gérard, A Archimbaud, L Ollivaud, F Bouscarat, M Baccard, G Lanternier, P Saïag, C Lebbé, N Basset-Seguin, B Crickx, H Cave and B Grandchamp
Br J Cancer 90: 503-509; doi:10.1038/sj.bjc.6601503
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci FREE
W M Brown, E M Lange, H Chen, S L Zheng, B Chang, K E Wiley, S D Isaacs, P C Walsh, W B Isaacs, J Xu and K A Cooney
Br J Cancer 90: 510-514; doi:10.1038/sj.bjc.6601417
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma FREE
D Astuti, N F da Silva, A Dallol, D Gentle, T Martinsson, P Kogner, R Grundy, T Kishida, M Yao, F Latif and E R Maher
Br J Cancer 90: 515-521; doi:10.1038/sj.bjc.6601447
Molecular variants of the ATM gene in Hodgkin's disease in children FREE
E Liberzon, S Avigad, I Yaniv, B Stark, G Avrahami, Y Goshen and R Zaizov
Br J Cancer 90: 522-525; doi:10.1038/sj.bjc.6601522
Experimental Therapeutics
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity FREE
M-C Etienne, K Ilc, J-L Formento, P Laurent-Puig, P Formento, S Cheradame, J-L Fischel and G Milano
Br J Cancer 90: 526-534; doi:10.1038/sj.bjc.6601523
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer FREE
R Kuefer, M D Hofer, V Altug, C Zorn, F Genze, K Kunzi-Rapp, R E Hautmann and J E Gschwend
Br J Cancer 90: 535-541; doi:10.1038/sj.bjc.6601510
An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines FREE
V K Sangar, R Cowan, G P Margison, J H Hendry and N W Clarke
Br J Cancer 90: 542-548; doi:10.1038/sj.bjc.6601538
Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700) FREE
K Hori and S Saito
Br J Cancer 90: 549-553; doi:10.1038/sj.bjc.6601582
Letters to the Editor
Cellular radiosensitivity: do separate predictive parameters apply for fibroblasts and for human tumour cells? FREE
L Bohm
Br J Cancer 90: 554-555; doi:10.1038/sj.bjc.6601572
Reply: Tumour and normal cells differ in the induction and repair of DNA double-strand breaks FREE
J Dahm-Daphi, R A El-Awady and E Dikomey
Br J Cancer 90: 556; doi:10.1038/sj.bjc.6601573
Book Reviews
Lentivirus Gene Engineering Protocols FREE
Y Takeuchi
Br J Cancer 90: 557; doi:10.1038/sj.bjc.6601433
Human Embryonic Stem Cells FREE
M Clements
Br J Cancer 90: 558-559; doi:10.1038/sj.bjc.6601577
Ovarian cancer – American cancer society atlas of clinical oncology FREE
J A Ledermann
Br J Cancer 90: 559; doi:10.1038/sj.bjc.6601435
Principles and Practice of Head and Neck Oncology FREE
R S Weber and K B Pytynia
Br J Cancer 90: 560; doi:10.1038/sj.bjc.6601592
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
